Literature DB >> 24704474

Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ.

Xiujing Feng1, Haohan Qin1, Qian Shi2, Yang Zhang1, Feifei Zhou1, Haochen Wu1, Sen Ding1, Zhiyuan Niu1, Yan Lu3, Pingping Shen4.   

Abstract

Chrysin (5,7-di-OH-flavone), a widely distributed natural flavonoid, has been well documented for involving in various biological activities, especially in regulation of peroxisome proliferator activated receptor γ (PPARγ) activity as a modest modulator. However, the exact molecular mechanism is still unrevealed. In the current study, for the first time, we discovered that, chrysin not only significantly attenuated inflammation in high-fat feeding mice, but also alleviated high fat diet-induced hepatic, muscular steatosis in obese mice without altering the body weight. Chrysin decreases the infiltration of macrophages into adipose tissue in obese mice. In addition, chrysin was also found to induce an anti-inflammatory M2 phenotype and decreases M1 phenotype, both in peritoneal macrophages of obese mice and cultured macrophages in vitro, and thereby, chrysin changed the M1/M2 status. Our data further showed that chrysin regulated the phenotype of macrophages through enhancing the transcriptional activation of PPARγ and the expression of its target genes. Taken together, we conclude that chrysin may serve as an effective modulator of PPARγ during the pathogenesis of inflammation, thereby our findings shed light on the potential therapeutic feature of chrysin in recovering inflammatory diseases via regulating M1/M2 status.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chrysin; Inflammation; M1/M2 status; PPARγ

Mesh:

Substances:

Year:  2014        PMID: 24704474     DOI: 10.1016/j.bcp.2014.03.016

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  27 in total

1.  Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.

Authors:  Min-Kyung Kang; Sin-Hye Park; Yean-Jung Choi; Daekeun Shin; Young-Hee Kang
Journal:  J Mol Med (Berl)       Date:  2015-06-11       Impact factor: 4.599

2.  Preventive Effects of Protocatechuic Acid on LPS-Induced Inflammatory Response in Human Gingival Fibroblasts via Activating PPAR-γ.

Authors:  Yimin Wang; Jun Zhou; Sheng Fu; Cheng Wang; Bing Zhou
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

3.  Ameliorative impacts of chrysin against gibberellic acid-induced liver and kidney damage through the regulation of antioxidants, oxidative stress, inflammatory cytokines, and apoptosis biomarkers.

Authors:  Mohamed Mohamed Soliman; Adil Aldhahrani; Ahmed Gaber; Walaa F Alsanie; Wafaa Abdou Mohamed; Mohamed M M Metwally; Mohamed Elbadawy; Mustafa Shukry
Journal:  Toxicol Res (Camb)       Date:  2022-02-03       Impact factor: 3.524

Review 4.  Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry.

Authors:  Xiran Lin; Xianmin Meng; Zhiqi Song; Jingrong Lin
Journal:  Mol Cell Biochem       Date:  2022-03-29       Impact factor: 3.396

5.  Effects of Citral on Lipopolysaccharide-Induced Inflammation in Human Umbilical Vein Endothelial Cells.

Authors:  Yan Song; Hongfeng Zhao; Jinyang Liu; Chao Fang; Renying Miao
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

6.  Blocking fatty acid-fueled mROS production within macrophages alleviates acute gouty inflammation.

Authors:  Christopher J Hall; Leslie E Sanderson; Lisa M Lawrence; Bregina Pool; Maarten van der Kroef; Elina Ashimbayeva; Denver Britto; Jacquie L Harper; Graham J Lieschke; Jonathan W Astin; Kathryn E Crosier; Nicola Dalbeth; Philip S Crosier
Journal:  J Clin Invest       Date:  2018-03-26       Impact factor: 14.808

7.  Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats.

Authors:  Badreldin H Ali; Sirin A Adham; Mohammed Al Za'abi; Mostafa I Waly; Javed Yasin; Abderrahim Nemmar; Nicole Schupp
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

8.  Inhibition of TGF-β by a novel PPAR-γ agonist, chrysin, salvages β-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism.

Authors:  Neha Rani; Saurabh Bharti; Jagriti Bhatia; Ameesha Tomar; T C Nag; Ruma Ray; Dharamvir Singh Arya
Journal:  Nutr Metab (Lond)       Date:  2015-03-09       Impact factor: 4.169

Review 9.  The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Detlef Schuppan; Henning Grønbæk; Konstantin Kazankov; Simon Mark Dahl Jørgensen; Karen Louise Thomsen; Holger Jon Møller; Hendrik Vilstrup; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

10.  Activation of PPARγ by a Natural Flavonoid Modulator, Apigenin Ameliorates Obesity-Related Inflammation Via Regulation of Macrophage Polarization.

Authors:  Xiujing Feng; Dan Weng; Feifei Zhou; Young D Owen; Haohan Qin; Jingfa Zhao; Yahong Huang; Jiajia Chen; Haijian Fu; Nanfei Yang; Dianhua Chen; Jianxin Li; Renxiang Tan; Pingping Shen
Journal:  EBioMedicine       Date:  2016-06-15       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.